Overview

Since around 2019, youth gender medicine has produced a run of public controversies: staff who went public with concerns, studies that were not published, guideline bodies accused of bending evidence, charities and private clinics criticised by regulators, and hospitals that settled with governments. This hub collects the cases that can be checked against primary sources: court records, regulator decisions, official reports, sworn statements and mainstream reporting. It sets out what was alleged, how each institution responded, and where each case stood in October 2026.

Eleven cases have their own pages. On the guideline bodies: the WPATH Files and the evidence controversy at the World Professional Association for Transgender Health (WPATH), the Endocrine Society's guideline and its conflicts of interest and the American Academy of Pediatrics. On clinics and hospitals: the Tavistock Gender Identity Development Service (GIDS), the Washington University Transgender Center, Texas Children's Hospital, Sweden's Karolinska and the Uppdrag granskning investigations and Australia's Queensland and Royal Children's Hospital cases. On research, charities and online prescribing: the unpublished US National Institutes of Health (NIH) puberty blocker study, the UK youth gender charity Mermaids and the online clinic GenderGP. For the wider evidence picture, see evidence reviews; for patients suing their providers, see detransitioner lawsuits.

Four recurring patterns

Read together, the cases show four patterns. Each turns up in several countries and was found by people with no connection to each other.

• Whistleblowers inside clinics. Case managers, therapists, psychiatrists and surgeons said patients with complex mental health histories were being moved quickly to medical treatment and that colleagues who raised concerns were sidelined. Examples include Jamie Reed in St Louis, Tamara Pietzke in Washington state, Jillian Spencer in Brisbane, and earlier the Tavistock staff described on the GIDS page.
• Evidence that was suppressed, delayed or missing. These include an NIH-funded puberty blocker study left unpublished partly over fears it would be "weaponized", systematic reviews that WPATH commissioned but did not publish in full, adult clinics in England declining to share follow-up data with the Cass Review (England's independent review of youth gender services), and clinics that never tracked outcomes in the first place.
• Conflicts of interest and self-referential guidelines. The bodies that wrote the main guidelines were often also professional and advocacy groups for the clinicians delivering the care. The University of York found that most national guidelines drew on just two international documents, WPATH and the Endocrine Society, which were themselves of limited rigour (Taylor et al. 2024).
• Regulatory and institutional failure. Problems included unlicensed or poorly monitored online prescribing, charities handing out medical-adjacent products without telling parents, hospitals billing public insurance in ways prosecutors called improper, and regulators who acted slowly or, in some cases, against the person raising the concern.

Verified cases at a glance

Show details: cases considered but not treated as verified scandals

• Boston Children's Hospital (2022). Viral posts said the hospital performed hysterectomies on minors. Fact-checkers and the hospital said the posts were misleading; the hospital then received bomb threats, and a Massachusetts woman was arrested over one hoax call (Boston.com). In 2025 a federal judge quashed a DOJ subpoena to the hospital as "motivated by bad faith". The 2022 episode is better described as a misinformation and harassment case than a verified scandal.
• Children's National, Washington DC (2022). Phone operators told an activist that hysterectomies were available to minors. The hospital said this was incorrect (NPR).
• Policy reversals without wrongdoing findings. New Zealand's evidence brief (November 2024) and its ban on new puberty blocker prescriptions (from 19 December 2025) were government responses to weak evidence, not findings against any clinic (Ministry of Health). The same goes for Finland and Norway. These are covered under evidence reviews.
• The Dutch protocol (the Dutch model of puberty blockers, then hormones, then surgery for adolescents). Methodologists have criticised the original Dutch studies, and Dutch public television (Zembla, October 2023) aired a two-part documentary saying the evidence was insufficient (Zembla). This is a scientific dispute, not a misconduct case.

Guideline bodies

WPATH and the WPATH Files

The World Professional Association for Transgender Health (WPATH) writes the Standards of Care, the most widely cited guideline for medical transition. Leaked forum posts and a panel recording (the WPATH Files, March 2024), court-unsealed documents showing that WPATH restricted publication of the Johns Hopkins evidence reviews it had commissioned, and the removal of age minimums from SOC8 after pressure from US officials all raised questions about how its guidance was made. On 17 June 2026 the FTC and four states sued WPATH in Texas over allegedly deceptive claims (FTC). WPATH argues the challenged statements are "non-actionable opinions", and the case was pending in October 2026. Full account: the WPATH Files.

The Endocrine Society guideline

The Endocrine Society's 2017 guideline, co-sponsored by WPATH, rated the evidence for every adolescent recommendation "low" or "very low" yet made several of them "strong". At least seven of its ten authors have held WPATH roles or written WPATH standards, and the York appraisal for the Cass Review did not recommend it for use (Taylor et al. 2024). A revision announced in 2024 had not appeared by October 2026. The Society calls the guideline conservative and evidence-based. Full account: the Endocrine Society.

American Academy of Pediatrics

The AAP's 2018 policy statement endorsed the affirmative model. Peer-reviewed citation checks in 2019 and 2025 reported that several of its cited papers did not support, or even contradicted, the claims made for them, particularly on desistance (gender distress resolving without transition) and "watchful waiting" (Cantor 2019; Archives of Sexual Behavior 2025). In August 2023 the board reaffirmed the statement and authorised a systematic review (AAP News); by October 2026 none had been published. HHS says the AAP declined its invitation to peer-review the 2025 federal evidence review (HHS peer-review supplement).

The FTC sent the AAP a civil investigative demand in January 2026 (FTC order) and withdrew it on 17 June 2026. The AAP's own suit against the FTC was closed on 24 August 2026. Florida's December 2025 consumer-protection and racketeering suit against the AAP, WPATH and the Endocrine Society goes on in Florida state court: the AAP dropped its federal suit in Illinois to block it, and the full Seventh Circuit closed the appeal on 14 September 2026. No court has ruled that the AAP misled anyone. Full account: the American Academy of Pediatrics.

United States

Washington University Transgender Center (Jamie Reed)

In February 2023 Jamie Reed, a former case manager at the Washington University Transgender Center at St. Louis Children's Hospital, said in a sworn affidavit that blockers and hormones were given to children with serious untreated mental health problems, that families were told little about side effects, and that nobody tracked outcomes (Reed affidavit, Missouri AG). The university's internal review called the allegations "unsubstantiated" (AP). Some families disputed her account, and The New York Times found some claims corroborated and at least one inaccurate.

Outcome: The centre stopped prescribing blockers and hormones to minors in September 2023, citing liability under Missouri's new law (WashU statement). A trial judge found Reed credible when upholding that law in 2024, and the Missouri Supreme Court upheld it in January 2026. The attorney general's investigation had produced no public findings by October 2026. A September 2025 appeals ruling sent the dispute over patient records back to the trial court. No court or regulator has proven or disproven her specific allegations. Full account: Washington University Transgender Center.

Texas Children's Hospital (Eithan Haim)

In March 2022 Texas Children's Hospital, the largest children's hospital in the US, announced a pause on hormone therapies for gender-affirming care. In May 2023 Dr Eithan Haim, a surgeon who had trained there, gave redacted records to the writer Christopher Rufo indicating that treatment of minors had continued. Federal charges against Haim under HIPAA, the US health-privacy law, were dismissed with prejudice on a joint motion in January 2025, before trial (Courthouse News). His malicious-prosecution suit against the hospital and Baylor College of Medicine is pending.

On 15 May 2026 the hospital settled billing-fraud allegations with the Texas attorney general and the US Department of Justice, without admitting wrongdoing. It pays $10 million: $8.576 million to Texas and $1.424 million to the US, of which $2 million goes to the whistleblower who brought the underlying qui tam suit (a whistleblower lawsuit filed on the government's behalf). It must permanently stop transition procedures for patients of any age, remove privileges from three current physicians and bar two former ones, and open a free detransition clinic (Texas Attorney General; NBC News). Under the final agreement it also had to withdraw its 15 May statement and acknowledge that its providers had performed the procedures. Full account: Texas Children's Hospital.

Vanderbilt University Medical Center

In September 2022 the commentator Matt Walsh (Daily Wire) posted clips from Vanderbilt. One was a 2018 talk in which a clinic doctor described gender-affirming procedures as "huge money makers" for hospitals. Another showed a staff member saying that clinicians with religious objections should expect consequences. Tennessee's governor called for an investigation (AP via Washington Post). Vanderbilt said the posts misrepresented the facts, then paused gender surgery for minors.

The state attorney general opened a billing-fraud investigation, saying he had been tipped off that "a VUMC doctor publicly described her manipulation of medical billing codes to evade coverage limitations." Vanderbilt handed over patient records from 2018 onward, which prompted lawsuits from patients (AP). Tennessee's 2023 ban on treatment for minors was upheld by the US Supreme Court in United States v. Skrmetti (June 2025). We found no public resolution of the billing investigation.

The unpublished NIH puberty blocker study (Olson-Kennedy, CHLA)

From 2015 an NIH-funded study led by Dr Johanna Olson-Kennedy of Children's Hospital Los Angeles (CHLA) followed 95 children starting puberty blockers. In October 2024 she told The New York Times that she had not published results showing no improvement in mental health, partly because "I do not want our work to be weaponized" (NYT). A preprint posted in May 2025 reported that depression symptoms "did not change significantly over 24 months"; it has still not been peer reviewed (Olson-Kennedy et al. 2025, medRxiv). In August 2026 the Oversight Project, a conservative watchdog, obtained and released the final NIH report, which described mental health as "relatively stable" (Daily Signal, conservative). No official body has found research misconduct; the case is about delayed publication and how results were presented.

CHLA closed its youth gender centre on 22 July 2025, citing federal funding threats, not the study (Los Angeles Times). Full account: the unpublished NIH puberty blocker study; see also Breen v. Olson-Kennedy.

Other US whistleblowers

Tamara Pietzke, a therapist at MultiCare in Washington state, wrote in February 2024 that she had been pressured to approve every teenager referred for transition and had resigned rather than comply (The Free Press). A Washington state licensing complaint against her was later dropped, according to an advocacy outlet (IWFeatures). The 2025 HHS evidence review has a section on whistleblowers (HHS review, pre-peer-review version), including Laura Edwards-Leeper and Erica Anderson, whose 2021 Washington Post essay argued that the mental health establishment was failing these young people (Washington Post), as well as Reed and Pietzke.

Federal investigations (2025–26)

Under the second Trump administration the federal government moved from criticism to enforcement. In July 2025 the Department of Justice issued more than 20 subpoenas to clinics and doctors. Courts quashed the subpoenas to Boston Children's Hospital and the online clinic QueerDoc, and the Boston judge called the subpoena "motivated by bad faith" (Reuters; National Law Review). In May 2026 Chief Judge James Boasberg enjoined the FTC's demands to WPATH and the Endocrine Society as likely First Amendment retaliation, citing "extensive evidence of animus" (Bloomberg Law). On 17 June 2026 the FTC withdrew its demands to WPATH, the Endocrine Society and the AAP, and it and four states sued WPATH for deceptive claims instead (FTC). The Texas Children's settlement was the first resolution to come out of this federal-state enforcement.

United Kingdom

Mermaids

Mermaids is a charity for gender-questioning young people. After The Telegraph reported in September 2022 that it had offered chest binders to children without their parents' agreement, the Charity Commission opened a compliance case and, in November 2022, a statutory inquiry. The October 2024 report found that the charity issued 125 binders between January 2021 and September 2022, 24 of them to young people it judged "unsupported" at home, and that its governance had not kept pace with its growth. It concluded this was mismanagement but not misconduct, and found no evidence that Mermaids gave medical advice or had inappropriate ties to the Tavistock or private prescribers (Charity Commission).

The Commission required Mermaids to remove its claim that puberty blockers are reversible, and said any future binder service must follow the Cass Review on involving parents. Mermaids had already ended the binder service in October 2023. It said it was "relieved"; some critics called the report a "whitewash" (GB News). Full account: Mermaids.

GenderGP and the Webberleys

GenderGP is an online service founded in 2015 by the doctors Helen and Michael Webberley. It offered remote prescriptions of hormones and puberty blockers, including to children. In 2018 Helen Webberley was convicted of running an unregistered online service in Wales and fined £12,000 (Manchester Evening News); she admitted that conviction before her later tribunal, and we found no record that it was overturned. In May 2022 a tribunal struck Michael Webberley off the register over failings in 25 patients' care, including puberty blockers prescribed to a nine-year-old (Telegraph).

In June 2022 a separate tribunal found Helen Webberley guilty of misconduct and suspended her for two months (BBC). In March 2023 the High Court quashed that misconduct finding without ordering a rehearing, while noting "concerns about certain aspects" of her practice (BBC). The appeal did not affect the 2018 conviction. Her licence to practise was withdrawn in July 2024 after she did not revalidate. Singapore, where GenderGP is now based, sent it a warning in October 2024 and blocked its websites in December 2024 (Straits Times). Full account: GenderGP.

Tavistock GIDS and missing data

The Tavistock GIDS, once the largest youth gender clinic in the world, closed at the end of March 2024 after years of staff warnings, an "inadequate" rating from the Care Quality Commission (England's health and care regulator) and the Cass Review's finding that a single national service was "not a safe or viable long-term option". Its own page covers that history. A related scandal received less attention. The Cass Review commissioned a data linkage study to follow about 9,000 young people who had passed from GIDS into adult services, and all but one adult gender clinic declined to take part (Cass 2024; Society for Evidence-Based Gender Medicine summary). NHS England's later review of the adult clinics, led by Dr David Levy and published in December 2025, found waits of more than five years and an "unacceptable" lack of outcome and safety data (BMJ). In February 2026 the government made an order allowing the study to go ahead (legislation.gov.uk), but no outcome results had been published by October 2026. Many services had never recorded what happened to their patients in the first place.

Europe

Sweden: Karolinska and Uppdrag granskning

Between 2019 and 2021 SVT's investigative programme Uppdrag granskning broadcast a series on youth gender care. "Tranståget och tonårsflickorna" ("The trans train and the teenage girls", April 2019) and a follow-up that October looked at the rise in teenage girls seeking transition and at young people who regretted it; Sweden's broadcasting review board later found the first programme breached a privacy rule. In spring 2021 Karolinska University Hospital stopped starting hormonal treatment for minors outside approved research.

In November 2021 "Transbarnen" ("The trans children") reported that at least 13 minors treated in Stockholm's youth gender services had suffered serious side effects or care injuries that Karolinska doctors knew about but the hospital had not made public. They included "Leo", who developed bone loss and changes in two vertebrae after starting blockers at 11 (SVT). In February 2022 the National Board of Health and Welfare judged that the risks of blockers and hormones probably outweigh the benefits and limited them to exceptional cases or research, and in March 2022 Karolinska filed a mandatory self-report to the national inspectorate over Leo's care; we could find no public outcome. Sweden is one of the clearest cases of journalism directly changing clinical policy. Full account: Sweden: Karolinska.

Australia and Canada

Queensland: Jillian Spencer and the hormone pause

Dr Jillian Spencer, a child and adolescent psychiatrist at Queensland Children's Hospital, was stood down in April 2023 after criticising the hospital's gender service, and was issued a termination notice in September 2025. In July 2026 Children's Health Queensland settled. Its statement accepted that her concerns "were grounded in her training and background as an experienced child and adolescent psychiatrist", and all disciplinary proceedings were discontinued; the terms are confidential (Sydney Morning Herald).

Separately, in January 2025 the Queensland government paused new puberty blocker and hormone treatment for under-18s in public hospitals, after clinical governance concerns at the Cairns Sexual Health Service (Queensland Government). In October 2025 the Supreme Court set the pause aside on procedural grounds, and the health minister reimposed it by ministerial direction the same day. In December 2025, after a review led by psychiatrist Ruth Vine, it was extended until the UK's PATHWAYS trial of puberty blockers reports, expected around 2031 (Guardian). Full account: Australia.

Victoria: the Royal Children's Hospital judgment

In April 2025, in Re Devin, Justice Andrew Strum of the Federal Circuit and Family Court refused puberty blockers for a child of 11 and was sharply critical of expert evidence from Dr Michelle Telfer, a senior clinician at the Royal Children's Hospital Melbourne gender service and lead author of Australia's national treatment guideline. In June 2025 he allowed the hospital and Dr Telfer to be named. The health regulator Ahpra later took no action on a complaint against her. The judgment could not be read in full, so this summary relies on reproductions of The Australian's reporting by gender-critical groups (Feminist Legal Clinic, reproducing The Australian); treat it with corresponding caution. Nationally, the National Health and Medical Research Council (NHMRC) is writing new guidelines, due in final form in April 2028. Full account: Australia.

Canada: the Zucker case

Canada's best-documented case points the other way. In 2015 Toronto's Centre for Addiction and Mental Health (CAMH) closed its youth gender clinic, led by psychologist Kenneth Zucker, which used a cautious, exploratory approach. It did so after an external review that critics saw as driven by activism. In 2018 CAMH apologised "without reservation" for errors in that review and paid Zucker C$586,000 (CBC). The case shows that pressure on institutions could also run against clinicians who urged caution, which is consistent with the whistleblower pattern above.

Incentives

Scandals rarely need a villain. Institutions behave predictably when their incentives point one way. The evidence on incentives is uneven, and this section separates what is documented from what is merely alleged.

Ideological and institutional incentives

• Guideline writers were also advocates and providers. WPATH is both a professional membership association and the author of the most widely used standards of care. The York team found that most guidelines worldwide derived from WPATH and the Endocrine Society, and that guidelines often cited each other rather than the underlying evidence, producing a circular chain of endorsement (Taylor et al. 2024). Systematic reviews commissioned by WPATH and the Endocrine Society rated the evidence low or very low, yet strong recommendations followed (Block 2023).
• Political strategy shaped clinical content. Unsealed court documents show SOC8's draft minimum ages were removed after US officials worried they would fuel restrictive laws (see the WPATH page). Olson-Kennedy's own stated reason for delay was a fear that results would be "weaponized".
• Exploration was recast as harm. D'Angelo argues that clinicians who explore why a young person wants to transition are increasingly cast as practising "conversion therapy", which discourages the assessment that the evidence gaps call for (D'Angelo 2025). The CAMH, Spencer and Pietzke cases show the professional cost of dissent, and are discussed further under backlash against detransitioners.

Financial incentives

• Documented statements. The 2018 Vanderbilt talk described gender procedures as "huge money makers" (AP via Washington Post). That shows how some staff pitched the service internally. It does not show that clinical decisions were made for money.
• Billing. Tennessee's investigation began with an allegation that billing codes were manipulated to get around coverage limits. The Texas settlement resolved allegations of false diagnosis codes in Medicaid billing, which the hospital denied (Texas Attorney General). Neither case produced a court finding of fraud.
• Scale. Insurance-claims data analysed for Reuters found about 42,000 US children and teens diagnosed with gender dysphoria in 2021, nearly triple the 2017 figure. Between 2017 and 2021, at least 4,780 started puberty blockers and 14,726 started hormones, figures Reuters called likely undercounts (Reuters). A service line of that size creates institutional stakes in its continuation, whatever the motives of individual clinicians.
• Alleged profit from claims. The FTC's 2026 complaint alleges that WPATH's representations helped its members sell paediatric transition services. That is an allegation in litigation, brought by an administration a federal judge found had shown animus against WPATH in a parallel dispute (FTC complaint).

Against this, the Charity Commission found no inappropriate financial ties between Mermaids and private clinics, and no case on this page has produced a proven finding that clinicians prescribed for profit. On the documented record, the stronger explanation is ideological conviction, reinforced by institutional momentum and fear of being called transphobic, with money as a background condition rather than the main driver.

Criticisms of the "scandal" framing

The institutions and their defenders make several arguments, and some of them are sound.

• Some allegations failed. Washington University's internal review rejected Reed's central claims, and some families disputed her account. Boston Children's was targeted over claims that fact-checkers called misleading. The Charity Commission found mismanagement at Mermaids but no misconduct, and Helen Webberley's 2022 misconduct finding was quashed on appeal (her 2018 conviction for running an unregistered service was not).
• Privacy and process matter. Haim's disclosures exposed patient information, even though redacted, and the prosecution's stated concern was patient privacy. Vanderbilt's handover of records to the state alarmed families. Some whistleblowers went to partisan media rather than through regulators, which made their claims harder to separate from political campaigns.
• Politics drove much of the enforcement. The DOJ and FTC actions came with explicit political goals, and courts repeatedly called them retaliatory or in bad faith. CHLA closed because of funding threats, not a finding about its care. Several "outcomes" are therefore outcomes of political power, not proof of wrongdoing.
• Critiques of the reviews. Defenders of the affirmative model point to peer-reviewed critiques of the Cass Review (McLamore et al. 2025) and the Yale Integrity Project paper. Those critiques have in turn been answered in Archives of Disease in Childhood, which described the Yale paper as written for litigation rather than scholarship (ADC 2025).

These points narrow what can be claimed, but they do not erase the pattern. Even the documents least open to dispute (the Mermaids report, the Webberley tribunal findings, the Karolinska self-report, the Levy review, the NYT interview and the Texas settlement) record failures of assessment, consent, data or transparency. That is consistent with what the national evidence reviews found.

What detransitioners say

Many r/detrans commenters read these cases as confirming their own experience: that they were told the risks were small and the evidence settled. Reactions to the unpublished blocker study were especially sharp.

Not publishing the findings because they're worried about what it would do politically is why we shouldn't immediately trust any study. Clearly these people have an agenda and anything that goes against it either doesn't get published or gets "massaged" to meet whatever message they want to push. —chasingmars, detrans male

Several connect suppressed evidence with the "you knew the risks" response they meet after detransition:

I like how critics of detransitioners are always like "they knew the risks" but simultaneously try very, very hard to eliminate any evidence online anywhere of risks, regret, or bad results. —allADD, desisted male

Others describe the misinformation directly. One detrans female says her endocrinologist told her father "only 1% of ppl detrans… It's the only reason he let me transition" (SnooCompliments8762). Another describes the institutional defensiveness that whistleblowers also report:

I've found that healthcare professionals are very defensive and wary about detransitioners. It means admitting they provided the wrong treatment. Its easier to push that blame entirely onto the patient when you are still frequently providing that treatment to others. They don't want to be wrong, they want you to be just a glitch. —illinoisbeau, detrans female

A commenter who had once worked in a gender clinic described trying "to gently express some concerns I had about how I had seen kids being treated" online and being accused of lying (Icy_Owl7841, detrans). Not everyone assumes bad faith. One desisted female wrote that clinicians "aren't consciously doing things they think are harmful":

So if you're a hospital considering a large pile of money to be made from gender surgery and the "feel good" pat on the back on one side, and accusations of transphobia and no new money flow on the other, you can see how it might arise without anyone consciously trying to exploit people. —Top_Ad5385, desisted female

The Texas settlement drew mixed reactions. One detrans female said the deal sounded "like much more of a political move", a settlement "due to allegations/lawsuits of fraud" (aikolbee). Others saw it as the first institutional acknowledgment that detransitioners need dedicated care. For what that care involves, see detransition healthcare and the support directory.

Trans perspectives

Many trans commenters experience these same events as attacks on their healthcare. Clinic closures driven by federal pressure left existing patients searching for new prescribers. Some were angry at hospitals for giving in without a fight:

Children's Hospital Los Angeles forced the Center for Trans Youth Health & Development (CTYHD) Clinic and associated Gender Affirming Surgery Clinic to shut down this past Tuesday because of the fear mongering around the EO. Beyond disgraceful on the hospital executives because they so easily folded without any pushback… —ftisthrowaway, trans man (FTM)

The worst part of this is that they didn't even wait to be told they had to do this. They bent the knee in advance and screwed over so many people! —Organic_Limit343, trans woman (MTF)

Many trans commenters regard the Cass Review as discredited. One cites the Yale paper: "The Cass Report was already debunked as nonsense by Yale" (son-of-may, trans man (FTM)). From this perspective, the "scandals" are a pretext for removing care. The record above shows that some enforcement was indeed politically motivated, as courts found. It also shows failures that no political motive explains: binders given to children without parents' knowledge, an important trial result kept from the public, injuries not disclosed, and outcome data never collected. People on both sides were badly served by a field that failed to gather and share the evidence it needed. That gap is at the heart of the informed consent critique.

Related pages

• WPATH Files and the evidence controversy
• Tavistock GIDS
• Endocrine Society guideline
• American Academy of Pediatrics
• Washington University Transgender Center
• Texas Children's Hospital
• The unpublished NIH puberty blocker study
• Mermaids
• GenderGP
• Sweden: Karolinska
• Australia: Queensland and the Royal Children's Hospital
• Evidence reviews: Cass and international policy shifts
• Detransitioner lawsuits
• Iatrogenic harm and puberty blockers
• Wikipedia and gender medicine
• The site's study archive and r/detrans statistics

References

• Cass, H. (2024). Independent review of gender identity services for children and young people: Final report. study page.
• Block, J. (2023). Gender dysphoria in young people is rising—and so is professional disagreement. The BMJ. study page, source.
• D'Angelo, R. (2025). Do we want to know? International Journal of Psychoanalysis. study page.
• Taylor, J. et al. (2024). Clinical guidelines for children and adolescents experiencing gender dysphoria or incongruence: a systematic review of guideline quality (part 1). Archives of Disease in Childhood. source.
• Cantor, J. M. (2019). Transgender and Gender Diverse Children and Adolescents: Fact-Checking of AAP Policy. Journal of Sex & Marital Therapy. source.
• Archives of Sexual Behavior (2025). Citation Issues in the American Academy of Pediatrics Policy Statement on Transgender and Gender-Diverse Children and Adolescents (Rafferty, 2018). source.
• American Academy of Pediatrics (2023). AAP reaffirms gender-affirming care policy, authorizes systematic review of evidence to guide update. source.
• Olson-Kennedy, J. et al. (2025). Mental and Emotional Health of Youth after 24 months of Gender-Affirming Medical Care Initiated with Pubertal Suppression (preprint). medRxiv. source.
• Ghorayshi, A. (2024). U.S. Study on Puberty Blockers Goes Unpublished Because of Politics, Doctor Says. The New York Times. source.
• Reed, J. (2023). Affidavit of Jamie Reed. Missouri Attorney General. source.
• Washington University (2023). Statement on Washington University Transgender Center. source.
• Associated Press (2023). Review finds no misconduct at Missouri trans youth clinic. source.
• Office of the Texas Attorney General (2026). Settlement with Texas Children's Hospital (press release, 15 May 2026). source.
• NBC News (2026). Texas Children's will create 'detransition clinic' to settle DOJ and state investigation. source.
• Courthouse News (2025). Judge dismisses charges against doctor accused of leaking child health care records. source.
• Associated Press (2022, 2023). Coverage of Vanderbilt University Medical Center and the Tennessee attorney general's investigation. 2022, 2023.
• U.S. Department of Health and Human Services (2025). Supplement to Treatment for Pediatric Gender Dysphoria: Peer Reviews and Replies. source.
• Federal Trade Commission (2026). FTC, States Sue WPATH (press release and complaint). press release, complaint.
• Federal Trade Commission (2026). Order Denying AAP Petition to Quash. source.
• Reuters (2025). Judge blocks Justice Department's transgender care subpoena to Boston Children's Hospital. source.
• Reuters (2022). Number of transgender children seeking treatment surges in U.S. source.
• Los Angeles Times (2025). End of transgender care at Children's Hospital L.A. signals nationwide shift. source.
• Charity Commission for England and Wales (2024). Charity Inquiry: Mermaids. source.
• BBC News (2022, 2023). Coverage of the Helen Webberley tribunal and High Court appeal. 2022, 2023.
• The Straits Times (2024). MOH warns British teleconsultation service to stop providing puberty blockers to S'pore users. source.
• BMJ (2025). "Unacceptable" waits and lack of safety data at adult gender clinics in England, review finds. source.
• SVT Uppdrag granskning (2021–22). Transbarnen and follow-ups. source.
• Queensland Government (2025). Media statement: Independent Review into puberty blockers. source.
• Sydney Morning Herald (2026). Psychiatrist settles years-long dispute with children's hospital. source.
• CBC News (2018). CAMH reaches settlement with former head of gender identity clinic. source.
• New Zealand Ministry of Health (2025). Puberty blockers (regulations). source.
• McLamore, Q. et al. (2025). Critically appraising the Cass report: methodological flaws and unsupported claims. BMC Medical Research Methodology. source.
• Archives of Disease in Childhood (2025). Gender medicine and the Cass Review: why medicine and the law make poor bedfellows. source.
• Edwards-Leeper, L. & Anderson, E. (2021). The mental health establishment is failing trans kids. Washington Post. source.
• Pietzke, T. (2024). I Was Told to Approve All Teen Gender Transitions. I Refused. The Free Press. source.
• UK Government (2026). The Gender Recognition (Disclosure of Information) (England) Order 2026. source.
• Partisan or advocacy sources used for specific details: Daily Signal (conservative); GB News (right-leaning broadcaster); SEGM (gender-critical evidence group); Feminist Legal Clinic (gender-critical); IWFeatures (conservative women's group).